Not Much Two decades ago, a team of doctors from Bordeaux, France, sparked a flurry of excitement in electrophysiology when they showed that ablation might deliver an easy fix for atrial fibrillation (AF).[1] This month, a patient asked me what was new in the treatment of AF. I paused ...
June 20, 2012 (Nice, France) — Here at Cardiostim 2012, two of the experts working on new European guidelines on stroke prevention in atrial-fibrillation patients gave a broad preview of how those guidelines will address the questions created by the introduction of several new anticoagulants [...
AC is recommended as first-line treatment in nearly all cases for primary and secondary stroke prevention. Most patients with new-onset afib found in the ED setting warrant AC, but systems of care and patient work-flows are underdeveloped to facilitate treatment initiation.Design/Methods: We ...
Finally, in AL amyloidosis there is increasing evidence that sequential monitoring of ECV on CMR can be important in monitoring treatment response [63]. CMR has some limitations. Importantly, it is still prohibitively expensive for some patients as CA is not currently listed as an item for ...
“As a company that has been dedicated to excellence and innovation in cardiac ablation for nearly three decades, Biosense Webster is excited about the potential of PFA in increasing access to treatment for patients around the world,” said Celine Martin, Company Group Chair...
The mRNA expression level of the myofibroblast marker ACTA2 showed both a slight but not significant increase in the basal expression level between control and Afib SF and an increase in expression after TGF-β 1 treatment (Fig. 1c, 14.4- vs. 10.1-fold upregulation). The mRNA ...
Create a free Seeking Alpha account to access breaking news and valuable research tools »Create Free AccountSeeking Alpha - Power to Investors Power to Investors Follow us Download app Account Account Login Manage My Portfolio Privacy Create Portfolio Portfolio Health Check Aler...
Apple VP of Health Dr. Sumbul Desai said in a statement "Heart health has always been a core focus of Apple Watch and we're thrilled to explore another opportunity for the powerful sensors in Apple Watch to help patients better manage their AFib treatment through the REACT-AF study...
"The WaveCrest®System is designed to enable physicians to close the heart's LAA, where most stroke-causing blood clots occur," said Dr. Chinitz. "For patients with AFib seeking an alternative to anticoagulants or blood thinners, this may be an important procedural option that could reduce ...
(n= 4698) found that preoperative treatment with beta-blockers resulted in a significant reduction in AFACS (16.3% vs 31.7%, OR 0.33, 95% CI 0.26–0.43,I2= 55%) [49]. In addition, many patients in the control groups stopped non-study beta-blockers to participate in the study ...